NETSPOT

Chemical Namegallium Ga 68 dotatate
Dosage FormInjection (intravenous; 2.1-5.45 mCi/mL)
Drug ClassRadioactive diagnostic agents
SystemEndocrine
CompanyAAA USA Inc.
Approval Year2016

Indication

  • For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.
Last updated on 10/15/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
NETSPOT (gallium Ga 68 dotatate) Prescribing Information 2019Advanced Accelerator Applications.,USA, Inc., NJ